Intrahepatic cholangiocarcinoma: management options and emerging therapies

Rebecca M Dodson; Matthew J Weiss; David Cosgrove; Joseph M Herman; Ihab Kamel; Robert Anders; Jean-Francois H Geschwind; Timothy M Pawlik

doi:10.1016/j.jamcollsurg.2013.05.021

Intrahepatic cholangiocarcinoma: management options and emerging therapies

J Am Coll Surg. 2013 Oct;217(4):736-750.e4. doi: 10.1016/j.jamcollsurg.2013.05.021. Epub 2013 Jul 24.

Authors

Rebecca M Dodson¹, Matthew J Weiss, David Cosgrove, Joseph M Herman, Ihab Kamel, Robert Anders, Jean-Francois H Geschwind, Timothy M Pawlik

Affiliation

¹ Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.

PMID: 23890842
DOI: 10.1016/j.jamcollsurg.2013.05.021

No abstract available

Keywords: AJCC; American Joint Committee on Cancer; EGFR; HBV; HCC; HCV; IBD; ICC; LN; PSC; VEGF; epidermal growth factor receptor; hepatitis B virus; hepatitis C virus; hepatocellular carcinoma; inflammatory bowel disease; intrahepatic cholangiocarcinoma; lymph node; primary sclerosing cholangitits; vascular endothelial growth factor.

Publication types

Review

MeSH terms

Bile Duct Neoplasms
Bile Ducts, Intrahepatic
Cholangiocarcinoma / epidemiology
Cholangiocarcinoma / pathology
Cholangiocarcinoma / therapy*
Humans
Liver Neoplasms / epidemiology
Liver Neoplasms / pathology
Liver Neoplasms / therapy*
Risk Factors
Survival Rate